Ozari vs Amble: $135 a Month — After $1,620 Leaves Your Account

Amble's pricing page carries one sentence that changes the whole calculation: "Total price represents a one time purchase paid upfront." The $135/month headline is real — but on the 12-month tier it means roughly $1,620 charged at once.

What Amble Publicly Lists

Amble (joinamble.com), run by Amble Health, Inc., sells a compounded GLP-1 injection program alongside NAD+, sermorelin, and other wellness products. Its GLP-1 page has listed per-month pricing by plan length:

• 1-month plan: $179/month
• 3-month plan: $160/month
• 6-month plan: $135–$145/month (the page shows both figures in separate plan tables)
• 12-month plan: $135/month

Multi-month plans are billed as a single up-front purchase, so the 12-month tier works out to about $1,620 paid on day one.

One structural detail stands out: the pricing table is labeled simply "Compounded GLP-1 injections." The page carries safety information for both semaglutide and tirzepatide, but does not publish separate prices for each drug. Which molecule you receive — and at what dose — is determined during the clinical process. If the distinction matters to you, and clinically it should, verify current drug-specific pricing directly with Amble.

Amble's genuine strengths: no membership fee, no insurance required, "same price, every dose" (with published fine print allowing price changes), free expedited cold shipping, HSA/FSA acceptance on 3-month-plus plans, and availability described as all 50 states with restrictions. A short video or audio visit is required in New Mexico, Kansas, West Virginia, Louisiana, and Mississippi. Medications are dispensed by state-licensed US pharmacies — 503A and 503B — though Amble does not name its pharmacy partners on the pricing page.

How the Models Compare

Amble and Ozari look similar at a glance: both are compounded-GLP-1 telehealth programs with flat bundled pricing and no membership fee. The differences sit in three places.

First, prepayment. Amble's better rates require buying 3, 6, or 12 months at once. Ozari's $86/month semaglutide starter and $145/month quarterly plan are paid as you go.

Second, price specificity. Ozari publishes separate semaglutide and tirzepatide prices ($86/$145/$175 and $125/$199/$235 across its plan tiers). Amble publishes one GLP-1 price ladder covering both molecules. Tirzepatide typically costs more to compound, so a single price covering either drug deserves a clarifying question before checkout.

Third, escalation. Dose increases are the norm in GLP-1 therapy. Amble's "same price at every dose" pledge is a real advantage over dose-tiered competitors — though its own disclosure notes the pledge can lapse within 24 hours of any price update. Ozari's plans are also dose-inclusive at the listed flat rates.

On reputation: Trustpilot's own profile for joinamble.com shows a 4.6 rating as of August 2026, consistent with the figure Amble cites on its site. The 100,000+ member count is a company statement rather than an audited number. Amble does not display a LegitScript seal on its site; check the LegitScript verification tool directly if certification matters to your decision.

The 12-Month Math

Amble, month-to-month:

• $179 × 12 = $2,148

Amble, prepaid 12-month plan:

• $135 × 12 = roughly $1,620, paid in one transaction

Ozari, semaglutide:

• Months 1–3: $257 (starter plan, ~$86/mo)
• Months 4–12: $145 × 9 = $1,305
• Year-one total: $1,562

Ozari, tirzepatide:

• Months 1–3: $125 × 3 = $375
• Months 4–12: $199 × 9 = $1,791
• Year-one total: $2,166

If Amble's $135 tier covers the drug you're prescribed, its prepaid year lands within $58 of Ozari's semaglutide year ($1,620 vs $1,562) — close enough that payment structure, not price, becomes the deciding factor. Ozari spreads $1,562 across twelve charges; Amble asks for the full amount before your first dose-adjustment conversation. Against Amble's month-to-month rate, Ozari's semaglutide year saves $585.

**A note from our clinical team:** One price ladder covering two different molecules means you must know exactly which one you are injecting. Semaglutide and tirzepatide are not interchangeable, and there is no simple milligram-for-milligram conversion between them — a switch is a new titration, planned by a prescriber, not a swap. Keep every carton label until your course ends, and if you ever transfer care, hand those labels over so nobody has to guess what your body has been receiving.

Key Comparison Table

Red Flags — Avoid These Providers

How to Cancel Amble

Amble's Terms of Service, current as of August 2026, spell the process out. You can cancel future renewals at any time either through the patient dashboard or by emailing Amble support with your name, email address, and subscription information. Timing matters: cancellation requests must be received at least 15 days before your next billing date, or the cancellation may be processed for the following cycle instead — set a reminder well ahead of renewal. Refunds are tightly limited. Per the same terms, multi-month plans are charged in full at purchase and become non-refundable once any portion of your treatment has been filled, compounded, or shipped; medication already dispensed continues through the remainder of the paid term. A full refund applies only if Amble's providers determine the medication is not medically appropriate for you. The terms also state that customers agree not to dispute charges with their card issuer when services were delivered, so the moment to weigh the 3-, 6-, or 12-month commitment is before checkout, not after. Whenever you cancel, get written confirmation and screenshot both it and your dashboard's subscription status. Ozari publishes its cancellation terms at https://www.ozarihealth.com/refund-policy

Frequently Asked Questions

Does Amble really cost $135 a month?

That rate has applied to the prepaid 12-month plan (and one listed 6-month tier), billed as a single up-front purchase of roughly $1,620. Month-to-month, Amble has listed $179.

Does Amble price semaglutide and tirzepatide differently?

Its public pricing table lists one "Compounded GLP-1 injections" ladder covering both drugs' safety information, without separate per-drug prices. Confirm the price for your specific prescribed medication directly with Amble.

Is Amble's medication FDA-approved?

No. Amble's compounded formulations are not FDA-approved — Amble discloses this. The same applies to every compounded GLP-1, including Ozari's. Branded Wegovy, Ozempic, Zepbound, and Mounjaro are the FDA-approved options.

Can I use HSA/FSA funds at Amble?

Amble accepts HSA/FSA cards on plans of 3 months or longer and provides itemized receipts. Ozari accepts HSA/FSA across its plans.

Is Amble available in my state?

Amble describes availability as all 50 states with restrictions; five states (NM, KS, WV, LA, MS) require a brief video or audio visit. Verify your state directly.

How does Ozari's pricing work by comparison?

Semaglutide runs $86/month for the starter phase, then $145/month quarterly — $1,562 in year one, billed as you go rather than up front.

How do I cancel Amble?

Cancel future renewals through the patient dashboard or by emailing Amble support, at least 15 days before your next billing date, per Amble's Terms of Service. Prepaid multi-month plans are non-refundable once any medication has been filled, compounded, or shipped. Keep written confirmation.

This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Pricing reflects publicly listed figures as of August 2026 and may change; verify current pricing directly with each provider. Always consult a licensed healthcare provider before starting or changing treatment. Ozari Health connects patients with licensed independent providers who determine whether treatment is appropriate.

Sources

• https://joinamble.com/glp-1-injections
• https://joinamble.com/terms-of-service
• https://www.trustpilot.com/review/joinamble.com
• https://www.legitscript.com/websites/?checker_keywords=joinamble.com
• https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
• https://www.ozarihealth.com/compounded-semaglutide
• https://www.ozarihealth.com/compounded-tirzepatide
• https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026